BDTX Insider Trading

BDTX · full profile →Last filing Jun 26, 2026
Mixed · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$0
open market, 180d
Reporting Insiders
0
0 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Recent Form 4 Transactions

100 shown
DateInsiderRoleActionSharesPriceValue
Jun 26, 2026Campbell ShannonDirectorGrant(A)40K$0
Jun 26, 2026Raman PrakashDirectorGrant(A)40K$0
Jun 26, 2026Behbahani AliDirectorGrant(A)40K$0
Jun 26, 2026Kulkarni SamarthDirectorGrant(A)40K$0
Jun 26, 2026Menzel Garry EDirectorGrant(A)40K$0
Jun 26, 2026Dhingra KapilDirectorGrant(A)40K$0
Jun 19, 2026Raman PrakashDirectorGrant(A)8K$1.66$13K
Jun 19, 2026Behbahani AliDirectorGrant(A)9K$1.66$15K
Mar 20, 2026Behbahani AliDirectorGrant(A)7K$2.15$15K
Mar 20, 2026Raman PrakashDirectorGrant(A)6K$2.15$13K
Jan 21, 2026Hatzis-Schoch BrentSEE REMARKSGrant(A)250K$0
Jan 21, 2026Yurasov SergeyCHIEF MEDICAL OFFICERGrant(A)250K$0
Jan 21, 2026Velleca Mark A.PRESIDENT & CEO, DirectorGrant(A)600K$0
Jan 21, 2026Buck ElizabethCHIEF SCIENTIFIC OFFICERGrant(A)250K$0
Jan 21, 2026Jones ErikaSEE REMARKSGrant(A)200K$0
Dec 12, 2025Behbahani AliDirectorGrant(A)5K$2.76$14K
Dec 12, 2025Raman PrakashDirectorGrant(A)5K$2.76$13K
Sep 19, 2025Behbahani AliDirectorGrant(A)4K$3.35$14K
Sep 19, 2025Raman PrakashDirectorGrant(A)4K$3.35$13K
Jun 20, 2025Behbahani AliDirectorGrant(A)6K$2.33$14K
Jun 20, 2025Raman PrakashDirectorGrant(A)6K$2.33$13K
Jun 12, 2025Behbahani AliDirectorGrant(A)31K$0
Jun 12, 2025Kulkarni SamarthDirectorGrant(A)31K$0
Jun 12, 2025Dhingra KapilDirectorGrant(A)31K$0
Jun 12, 2025Campbell ShannonDirectorGrant(A)31K$0
Jun 12, 2025Raman PrakashDirectorGrant(A)31K$0
Jun 12, 2025Menzel Garry EDirectorGrant(A)31K$0
Mar 21, 2025Behbahani AliDirectorGrant(A)8K$1.88$14K
Mar 21, 2025Raman PrakashDirectorGrant(A)7K$1.88$13K
Mar 19, 2025Biotech Growth N V10% OwnerSell(S)400K$2.09$836K
Mar 19, 2025Biotech Growth N V10% OwnerSell(S)500K$2.12$1.1M
Mar 19, 2025Biotech Growth N V10% OwnerSell(S)1.0M$2.07$2.1M
Mar 19, 2025Biotech Growth N V10% OwnerSell(S)2.0M$2.00$4.0M
Mar 19, 2025Biotech Growth N V10% OwnerSell(S)1.0M$2.31$2.3M
Mar 19, 2025Biotech Growth N V10% OwnerSell(S)300K$1.94$582K
Mar 19, 2025Biotech Growth N V10% OwnerSell(S)584K$1.95$1.1M
Jan 30, 2025Hatzis-Schoch BrentSEE REMARKSGrant(A)75K$0
Jan 30, 2025Hatzis-Schoch BrentSEE REMARKSGrant(A)175K$0
Jan 30, 2025Jones ErikaSEE REMARKSGrant(A)75K$0
Jan 30, 2025Jones ErikaSEE REMARKSGrant(A)125K$0
Jan 30, 2025Buck ElizabethCHIEF SCIENTIFIC OFFICERGrant(A)75K$0
Jan 30, 2025Buck ElizabethCHIEF SCIENTIFIC OFFICERGrant(A)175K$0
Jan 30, 2025Yurasov SergeyCHIEF MEDICAL OFFICERGrant(A)75K$0
Jan 30, 2025Yurasov SergeyCHIEF MEDICAL OFFICERGrant(A)200K$0
Jan 30, 2025Velleca Mark A.PRESIDENT & CEO, DirectorGrant(A)75K$0
Jan 30, 2025Velleca Mark A.PRESIDENT & CEO, DirectorGrant(A)500K$0
Dec 13, 2024Behbahani AliDirectorGrant(A)6K$2.50$14K
Dec 13, 2024Campbell ShannonDirectorGrant(A)5K$2.50$11K
Dec 13, 2024Raman PrakashDirectorGrant(A)5K$2.50$13K
Sep 20, 2024Behbahani AliDirectorGrant(A)3K$4.78$14K
Sep 20, 2024Raman PrakashDirectorGrant(A)3K$4.78$13K
Sep 20, 2024Campbell ShannonDirectorGrant(A)2K$4.78$11K
Aug 28, 2024Versant Voyageurs I Parallel, L.P.10% OwnerSell(S)222K$6.32$1.4M
Jun 21, 2024Behbahani AliDirectorGrant(A)3K$4.98$14K
Jun 21, 2024Campbell ShannonDirectorGrant(A)2K$4.98$10K
Jun 21, 2024Raman PrakashDirectorGrant(A)2K$4.98$11K
Jun 6, 2024Behbahani AliDirectorGrant(A)31K$0
Jun 6, 2024Dhingra KapilDirectorGrant(A)31K$0
Jun 6, 2024Campbell ShannonDirectorGrant(A)31K$0
Jun 6, 2024Raman PrakashDirectorGrant(A)31K$0
Jun 6, 2024Menzel Garry EDirectorGrant(A)31K$0
Jun 6, 2024Kulkarni SamarthDirectorGrant(A)31K$0
Apr 10, 2024Raman PrakashDirectorGrant(A)61K$0
Apr 10, 2024Campbell ShannonDirectorGrant(A)61K$0
Mar 15, 2024Behbahani AliDirectorGrant(A)3K$4.54$14K
Mar 15, 2024Dixon Wendy LDirectorGrant(A)3K$4.54$15K
Feb 14, 2024Jones ErikaSEE REMARKSGrant(A)100K$0
Feb 14, 2024Velleca Mark A.PRESIDENT & CEO, DirectorGrant(A)537K$0
Feb 14, 2024Buck ElizabethCHIEF SCIENTIFIC OFFICERGrant(A)200K$0
Feb 14, 2024Yurasov SergeyCHIEF MEDICAL OFFICERGrant(A)225K$0
Feb 14, 2024Hatzis-Schoch BrentSEE REMARKSGrant(A)200K$0
Feb 14, 2024Ni FangSEE REMARKSGrant(A)200K$0
Dec 15, 2023Behbahani AliDirectorGrant(A)4K$2.73$12K
Dec 15, 2023Dixon Wendy LDirectorGrant(A)4K$2.73$11K
Oct 17, 2023Biotech Growth N V10% OwnerBuy(P)400K$2.34$936K
Sep 17, 2023Velleca Mark A.PRESIDENT & CEO, DirectorGrant(A)1.0M$0
Sep 15, 2023Behbahani AliDirectorGrant(A)3K$3.60$12K
Sep 15, 2023Dixon Wendy LDirectorGrant(A)3K$3.60$11K
Sep 15, 2023Velleca Mark A.PRESIDENT & CEO, DirectorGrant(A)5K$3.60$19K
Jul 5, 2023Ra Capital Management, L.P.DirectorBuy(P)936K$5.00$4.7M
Jul 5, 2023Behbahani AliDirectorBuy(P)1.0M$5.00$5.0M
Jun 30, 2023BB Biotech AG10% OwnerBuy(P)1.0M$5.00$5.0M
Jun 27, 2023Biotech Growth N V10% OwnerBuy(P)1.7M$5.49$9.6M
Jun 27, 2023Epstein David M.SEE REMARKS, DirectorSell(S)25K$6.70$168K
Jun 16, 2023Behbahani AliDirectorGrant(A)6K$2.10$12K
Jun 16, 2023Velleca Mark A.DirectorGrant(A)9K$2.10$19K
Jun 16, 2023Dixon Wendy LDirectorGrant(A)5K$2.10$11K
May 16, 2023Behbahani AliDirectorGrant(A)17K$0
May 16, 2023Dhingra KapilDirectorGrant(A)17K$0
May 16, 2023Dixon Wendy LDirectorGrant(A)17K$0
May 16, 2023Kulkarni SamarthDirectorGrant(A)17K$0
May 16, 2023Menzel Garry EDirectorGrant(A)17K$0
May 16, 2023Velleca Mark A.DirectorGrant(A)17K$0
May 16, 2023Shah Rajeev M.DirectorGrant(A)17K$0
May 16, 2023Mayweg AlexanderDirectorGrant(A)17K$0
Mar 16, 2023Behbahani AliDirectorGrant(A)7K$1.67$12K
Mar 16, 2023Velleca Mark A.DirectorGrant(A)11K$1.67$19K
Mar 16, 2023Dixon Wendy LDirectorGrant(A)6K$1.67$11K
Feb 13, 2023Hatzis-Schoch BrentSEE REMARKSGrant(A)200K$0
Feb 13, 2023Buck ElizabethCHIEF SCIENTIFIC OFFICERGrant(A)200K$0

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Coverage: Form 4 filings indexed 2021-03-292026-07-11. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).